Neotack 75 mg/5 ml (Syrup)
100 ml bottle: ৳ 50.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Ranitidine hydrochloride |
| Company | Square pharmaceuticals plc |
| Also available as |
Indications
- Treatment of active duodenal ulcer
- Benign gastric ulcer
- Prevention of ulcer associated with non-steroidal anti-inflammatory agent
- Post-operative stress ulcer
- Zollinger-Ellison Syndrome
- Gastroesophageal reflux disease (GERD)
- Gastrointestinal hemorrhage from stress ulcer in seriously ill patients
- Recurrent hemorrhage in patients with bleeding peptic ulcer
- Prevention of acid aspiration before general anesthesia in at-risk patients
Pharmacology
- Competitive blocking of histamine at H2-receptors
- Inhibition of gastric acid secretion
- No effect on pepsin secretion, intrinsic factor secretion, or serum gastrin
Dosage & Administration
- Usual dosage of 150 mg twice daily for 4 to 8 weeks for duodenal and gastric ulcer
- Dosage of 150 mg twice daily for up to 8 weeks for reflux esophagitis
- Dosage of 150 mg 3 times daily for Zollinger-Ellison syndrome
- Dosage of 150 mg twice daily for episodic dyspepsia
- Maintenance dosage of 150 mg at night for preventing recurrences
- Child dosage of 2-4 mg/kg twice daily, maximum 300 mg daily for peptic ulcer
Interaction
- Delayed absorption and increased peak serum concentration with propantheline bromide
- Minimal inhibition of hepatic metabolism of certain drugs
Contraindications
- Hypersensitivity to Ranitidine
Side Effects
- Altered bowel habit
- Dizziness
- Rash
- Tiredness
- Reversible confusional states
- Headache
- Decreased blood counts
- Muscle or joint pain
Pregnancy & Lactation
- Crosses the placenta
- Excreted in human breast milk
- Caution advised during lactation
Precautions & Warnings
- Reduced dosage for impaired renal and hepatic function
Use in Special Populations
- Ulcer healing rates similar in elderly patients
- No difference in adverse effects in elderly patients
Overdose Effects
- Specific in action, no particular problems expected
Therapeutic Class
- H2 receptor antagonist
Reconstitution
- Slow IV and intermittent slow IV infusion instructions
Storage Conditions
- Store in a cool and dry place
- Protect from light